MacroGenics: Q1 Earnings Snapshot
In this article:
ROCKVILLE, Md. (AP) — ROCKVILLE, Md. (AP) — MacroGenics Inc. (MGNX) on Tuesday reported a loss of $38 million in its first quarter.
On a per-share basis, the Rockville, Maryland-based company said it had a loss of 61 cents.
The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of $1.07 per share.
The biopharmaceutical company posted revenue of $24.5 million in the period, also missing Street forecasts. Three analysts surveyed by Zacks expected $129.7 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MGNX at https://www.zacks.com/ap/MGNX
